KF26777 (2-(4-bromophenyl)-7,8-dihydro-4-propyl-1H-imidazo[2,1-i]purin-5(4H)-one dihydrochloride), a new potent and selective adenosine A3 receptor antagonist (Q34133179)

From Wikidata

Jump to navigation Jump to search

scientific article

Language	Label	Description	Also known as
English	KF26777 (2-(4-bromophenyl)-7,8-dihydro-4-propyl-1H-imidazo[2,1-i]purin-5(4H)-one dihydrochloride), a new potent and selective adenosine A3 receptor antagonist	scientific article

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

31 July 2017

KF26777 (2-(4-bromophenyl)-7,8-dihydro-4-propyl-1H-imidazo[2,1-i]purin-5(4H)-one dihydrochloride), a new potent and selective adenosine A3 receptor antagonist (English)

1 reference

Europe PubMed Central

PubMed publication ID

31 July 2017

author name string

Mayumi Saki

1

1 reference

Europe PubMed Central

PubMed publication ID

31 July 2017

Hiroshi Tsumuki

2

1 reference

Europe PubMed Central

PubMed publication ID

31 July 2017

Hiromi Nonaka

3

1 reference

Europe PubMed Central

PubMed publication ID

31 July 2017

Junichi Shimada

4

1 reference

Europe PubMed Central

PubMed publication ID

31 July 2017

Michio Ichimura

5

1 reference

Europe PubMed Central

PubMed publication ID

31 July 2017

language of work or name

0 references

publication date

1 May 2002

1 reference

Europe PubMed Central

PubMed publication ID

31 July 2017

European Journal of Pharmacology

1 reference

Europe PubMed Central

PubMed publication ID

31 July 2017

444

1 reference

Europe PubMed Central

PubMed publication ID

31 July 2017

3

1 reference

Europe PubMed Central

PubMed publication ID

31 July 2017

133-141

1 reference

Europe PubMed Central

PubMed publication ID

31 July 2017

Some quantitative uses of drug antagonists

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2802%2901662-X

7 January 2021

Pyrazolo[4,3-e]-1,2,4-triazolo[1,5-c]pyrimidine derivatives as highly potent and selective human A(3) adenosine receptor antagonists

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2802%2901662-X

7 January 2021

A(3) adenosine receptor ligands: history and perspectives

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2802%2901662-X

7 January 2021

Relationship between the inhibition constant (K1) and the concentration of inhibitor which causes 50 per cent inhibition (I50) of an enzymatic reaction

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2802%2901662-X

7 January 2021

The effects of saponin on the binding and functional properties of the human adenosine A1 receptor

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2802%2901662-X

7 January 2021

Molecular cloning and expression of the gene for a human D1 dopamine receptor

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2802%2901662-X

7 January 2021

Adenosine A3 receptors on human eosinophils mediate inhibition of degranulation and superoxide anion release

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2802%2901662-X

7 January 2021

Adenosine A2A receptors mediate the inhibitory effect of adenosine on formyl-Met-Leu-Phe-stimulated respiratory burst in neutrophil leucocytes

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2802%2901662-X

7 January 2021

A3 adenosine receptor activation triggers phosphorylation of protein kinase B and protects rat basophilic leukemia 2H3 mast cells from apoptosis.

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2802%2901662-X

7 January 2021

Cloning of the cDNA and gene for a human D2 dopamine receptor

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2802%2901662-X

7 January 2021

Binding characteristics of 3H-prazosin to rat brain α-adrenergic receptors

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2802%2901662-X

7 January 2021

[3H]8-hydroxy-2-(di-n-propylamino)tetralin binding to pre- and postsynaptic 5-hydroxytryptamine sites in various regions of the rat brain

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2802%2901662-X

7 January 2021

An agonist of adenosine A3 receptors decreases interleukin-12 and interferon-gamma production and prevents lethality in endotoxemic mice

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2802%2901662-X

7 January 2021

The binding of [3H]mepyramine to histamine H1 receptors in guinea-pig brain

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2802%2901662-X

7 January 2021

Pharmacological characterization of novel A3 adenosine receptor-selective antagonists

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2802%2901662-X

7 January 2021

6-phenyl-1,4-dihydropyridine derivatives as potent and selective A3 adenosine receptor antagonists

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2802%2901662-X

7 January 2021

Structure-activity relationships of 4-(phenylethynyl)-6-phenyl-1,4-dihydropyridines as highly selective A3 adenosine receptor antagonists

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2802%2901662-X

7 January 2021

Synthesis and biological activities of flavonoid derivatives as A3 adenosine receptor antagonists

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2802%2901662-X

7 January 2021

2-Substitution of N6-benzyladenosine-5'-uronamides enhances selectivity for A3 adenosine receptors

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2802%2901662-X

7 January 2021

Derivatives of the triazoloquinazoline adenosine antagonist (CGS15943) are selective for the human A3 receptor subtype

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2802%2901662-X

7 January 2021

Induction of apoptosis in HL-60 human promyelocytic leukemia cells by adenosine A(3) receptor agonists.

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2802%2901662-X

7 January 2021

Synthesis, CoMFA analysis, and receptor docking of 3,5-diacyl-2, 4-dialkylpyridine derivatives as selective A3 adenosine receptor antagonists

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2802%2901662-X

7 January 2021

Cloned adenosine A3 receptors: pharmacological properties, species differences and receptor functions

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2802%2901662-X

7 January 2021

Molecular cloning of adenosine A1 and A2 receptors

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2802%2901662-X

7 January 2021

Activation of adenosine A3 receptors on macrophages inhibits tumor necrosis factor-alpha

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2802%2901662-X

7 January 2021

G-protein alpha-subunit expression, myristoylation, and membrane association in COS cells

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2802%2901662-X

7 January 2021

LIGAND: A versatile computerized approach for characterization of ligand-binding systems

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2802%2901662-X

7 January 2021

Adenosine receptors

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2802%2901662-X

7 January 2021

Molecular cloning and characterization of the human A3 adenosine receptor

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2802%2901662-X

7 January 2021

Disruption of the A(3) adenosine receptor gene in mice and its effect on stimulated inflammatory cells

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2802%2901662-X

7 January 2021

Inhibitory Effect of Adenosine on Degranulation of Human Cultured Mast Cells upon Cross-linking of FcϵRI

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2802%2901662-X

7 January 2021

Suppression of macrophage inflammatory protein (MIP)-1alpha production and collagen-induced arthritis by adenosine receptor agonists

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2802%2901662-X

7 January 2021

Interaction of mianserin, amitriptyline and haloperidol with guinea pig cerebral histamine H2 receptors studied with [125I]iodoaminopotentidine

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2802%2901662-X

7 January 2021

A novel class of adenosine A3 receptor ligands. 2. Structure affinity profile of a series of isoquinoline and quinazoline compounds

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2802%2901662-X

7 January 2021

Adenosine A3 receptor stimulation and cerebral ischemia

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2802%2901662-X

7 January 2021

Adenosine A3 receptor expression and function in eosinophils

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2802%2901662-X

7 January 2021

Pharmacological characterization of the novel nonpeptide angiotensin II receptor antagonist, BIBR 277

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2802%2901662-X

7 January 2021

Molecular cloning and characterization of an adenosine receptor: the A3 adenosine receptor

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2802%2901662-X

7 January 2021

Identifiers

10.1016/S0014-2999(02)01662-X

1 reference

Europe PubMed Central

PubMed publication ID

31 July 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

31 July 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q34133179&oldid=1540450924"